ArticleSarcoma2017

Early Evidence of Cardiotoxicity and Tumor Response in Patients with Sarcomas after High Cumulative Dose Doxorubicin Given as a Continuous Infusion.

Raymundo A Quintana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.